Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SAN DIEGO, December 20 /PRNewswire/ --

- Increases First Quarter Fiscal 2008 Revenue and Earnings per Share Guidance

Qualcomm Incorporated (Nasdaq: QCOM) today updated its financial guidance for the first fiscal quarter ending December 30, 2007.

The following statements are forward looking and actual results may differ materially. Please see "Note Regarding Forward-Looking Statements" at the end of this news release for a description of certain risk factors and Qualcomm's annual and quarterly reports on file with the Securities and Exchange Commission (SEC) for a more complete description of risks that may affect the forward looking statements.

Pro Forma Defined

MONTREAL, December 20 /PRNewswire/ --

- Introduces a Simpler Process Better Aligned with Industry Practices for 2008

Sipro Lab Telecom, the administrator of the G.729 Patent Pool which represents the essential IPR and has contributed to this popular communications standard developed by the G.729 Consortium members: France Telecom, Nippon Telegraph and Telephone Corporation, Mitsubishi Electric Corporation, and Universite de Sherbrooke, announced today that the patent royalty pricing options available to end-product manufacturers will be modified as of January 1st, 2008.

LONDON and CAMBRIDGE, England, December 20 /PRNewswire/ --

- ATRIPLA is a Landmark Achievement of Two Co-operating Companies

ATRIPLA (600 mg efavirenz / 200 mg emtricitabine / 245 mg tenofovir disoproxil as fumarate), launched today in the UK, is the first and only complete HIV treatment in one pill once-daily for virologically suppressed adults, and represents a new era in HIV therapy for these patients. (1,2) In a unique collaboration, two companies - Bristol-Myers Squibb and Gilead Sciences - have come together to develop a single treatment to improve the lives of people with HIV. ATRIPLA offers virologically suppressed adults effective and discreet HIV treatment in one pill, once daily.(2-5)

LOS ANGELES, December 20 /PRNewswire/ --

Live Nation (NYSE: LYV) announced today that it has entered into a long-term agreement with CTS Eventim which will enable Live Nation to launch its own ticketing business utilizing the most technologically advanced ticketing platform in the world. Live Nation will exclusively license the Eventim platform in North America, and Eventim will provide back office ticketing services in the UK and ticketing services across Europe. The new agreement will allow Live Nation to begin selling tickets on January 1st, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070220/LATU096LOGO)

EL SEGUNDO, California, December 20 /PRNewswire/ --

- New Agreement Expands Geographic Coverage

Computer Sciences Corporation (NYSE: CSC) today announced that it has signed a five-year, US$192 million information technology (IT) outsourcing contract renewal with TrygVesta, the second-largest insurance company in the Nordic region. The new agreement, which takes effect Jan. 1, 2008, expands geographic coverage throughout the region.

BERKELEY, California, December 20 /PRNewswire/ --

BookFinder.com has released the list of the top 10 most sought-after out-of-print books in the UK. Unlike traditional annual lists of bestselling books, this list consists of titles which readers seek out independently, without being biased by publishers' publicity machines.

The books represent diverse interests, including Angling Times articles, 1950s environmental disaster fiction, historical timepieces, and Madonna's somewhat less historical collection of racy photos (the only title to appear both on the U.S. and UK lists).